Do You Need a Prescription for Testosterone Cream?

The Short Answer: Testosterone Is a Controlled Substance

Testosterone cream, gel, or any other topical formulation that contains pharmaceutical-grade testosterone is a Schedule III controlled substance under the Controlled Substances Act. The DEA classification means that no pharmacy can dispense it and no person can legally possess it without a prescription from a licensed prescriber.

The FDA has approved several branded topical testosterone products, and every one of them carries a prescription-only label. Selling them over the counter would violate both the Controlled Substances Act and the Federal Food, Drug, and Cosmetic Act simultaneously.

Why Schedule III Matters for Patients

Schedule III status places testosterone in the same category as ketamine and anabolic steroids. Prescribers must follow specific record-keeping rules. Refills are limited. A pharmacist cannot dispense more than a 90-day supply at a time under most state laws.

The classification exists because testosterone misuse carries real physiologic risks: erythrocytosis, cardiovascular strain, suppression of the hypothalamic-pituitary-gonadal axis, and infertility. These are not hypothetical concerns. A 2020 analysis published in the Journal of Clinical Endocrinology and Metabolism found that men using testosterone therapy without documented hypogonadism had a significantly higher rate of infertility-related consultations within 24 months of starting treatment.

What the FDA Has Actually Approved

The FDA has cleared five major topical testosterone products for men with documented hypogonadism:

| Product | Concentration | Approved Dose Range | |---|---|---| | AndroGel 1% | 1% (10 mg/g) | 50 to 100 mg/day | | AndroGel 1.62% | 1.62% (16.2 mg/g) | 20.25 to 81 mg/day | | Testim 1% | 1% (10 mg/g) | 50 to 100 mg/day | | Vogelxo | 1% (10 mg/g) | 50 to 100 mg/day | | Fortesta | 2% (20 mg/g) | 10 to 70 mg/day |

Each of these requires a prescription, and each carries an FDA black-box warning about secondary exposure to women and children through skin contact. The warning is not theoretical. A 2009 FDA safety communication documented cases of premature puberty in children who had skin contact with a testosterone-using adult.

What About Over-the-Counter "Testosterone Creams"?

Products marketed as "testosterone cream" or "testosterone booster cream" without a prescription contain no pharmaceutical testosterone. Full stop.

Some contain dehydroepiandrosterone (DHEA), a precursor hormone the body can theoretically convert to testosterone. DHEA is classified as a dietary supplement under the Dietary Supplement Health and Education Act of 1994, not a drug, so it escapes FDA pre-market approval requirements. A 2013 systematic review in Clinical Endocrinology found that DHEA supplementation produced only marginal, inconsistent changes in serum testosterone in men, with no clinically meaningful effect on symptoms of hypogonadism.

Other OTC products use zinc, ashwagandha, fenugreek, or d-aspartic acid. A randomized controlled trial published in JAMA (N=788) found that men with low-normal testosterone who received testosterone supplementation showed objective improvements in sexual function and bone density that OTC supplements have never replicated in head-to-head comparisons.

The Labeling Problem

Supplement manufacturers cannot legally claim their product "raises testosterone." They are permitted to make structure-function claims ("supports healthy testosterone levels") without proving efficacy. The Federal Trade Commission has taken action against multiple supplement companies for deceptive advertising, but new products enter the market continuously.

Buying an OTC cream labeled "testosterone" does not mean you are getting testosterone. It means you are getting a product that someone named after testosterone.

Risks of Self-Treating With Unverified Products

Unverified products carry their own risks beyond simply not working. Contamination with unlabeled steroids has been documented in dietary supplements. A 2018 analysis reported in JAMA Internal Medicine found that 776 of 9,957 analyzed supplements (7.8%) contained at least one unapproved pharmaceutical ingredient. Some of those were anabolic steroids.

Compounded Testosterone Cream: Legal, but Still Prescription-Only

Compounded testosterone cream sits in a legal space that confuses many patients. It is not FDA-approved, meaning no compounding pharmacy has submitted a new drug application demonstrating safety and efficacy for that specific formulation. Compounded preparations are legal under Section 503A or 503B of the Food, Drug, and Cosmetic Act, but they still require a valid prescription from a licensed clinician.

How Compounding Works

A compounding pharmacy prepares a customized formulation based on a prescriber's order. Common reasons a clinician might prescribe compounded testosterone cream over an FDA-approved gel include:

• A need for a concentration not commercially available (e.g., 5% or 10% cream for scrotal application)
• Patient sensitivity to a carrier ingredient in branded products
• Cost considerations, since compounded preparations are sometimes less expensive
• Clinical preference for cream over gel texture and absorption profile

Scrotal application of compounded testosterone cream has attracted attention because scrotal skin is significantly more permeable. A study in Andrology found that scrotal application of 5% testosterone cream produced mean peak total testosterone levels approximately 3 times higher than standard axillary application of commercial 1% gel at equivalent milligram doses, with dihydrotestosterone (DHT) levels also substantially elevated.

Quality and Variability Concerns

Because compounded products bypass FDA manufacturing oversight, potency can vary between batches. The FDA has issued guidance recommending that patients and prescribers confirm the compounding pharmacy holds accreditation from the Pharmacy Compounding Accreditation Board (PCAB) or operates under 503B outsourcing facility standards. FDA's current compounding guidance provides the applicable regulatory framework.

How to Get a Legitimate Prescription for Testosterone Cream

Getting a legitimate prescription means going through a clinical evaluation. The American Urological Association (AUA) 2018 guideline on testosterone deficiency states: "Testosterone therapy should only be initiated in patients with symptoms and signs consistent with testosterone deficiency and documented low serum testosterone concentrations." That guideline is available through the AUA's site.

Step 1: Symptom Assessment

Symptoms of hypogonadism that warrant evaluation include decreased libido, erectile dysfunction, fatigue, depressed mood, reduced muscle mass, increased body fat, and difficulty concentrating. No single symptom is diagnostic. Clinicians use validated screening tools like the Androgen Deficiency in the Aging Male (ADAM) questionnaire to structure the history.

Step 2: Lab Testing

Two separate morning blood draws showing total testosterone below 300 ng/dL are required by most major guidelines to confirm the diagnosis. The Endocrine Society's 2018 Clinical Practice Guideline, published in the Journal of Clinical Endocrinology and Metabolism, recommends measuring total testosterone by a reliable assay and, when total testosterone is near the lower limit of normal, confirming with free testosterone using the equilibrium dialysis method.

A baseline panel typically includes:

• Total testosterone (morning, fasting preferred)
• Free testosterone or sex hormone-binding globulin (SHBG)
• Luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
• Complete blood count (hematocrit)
• Prostate-specific antigen (PSA) in men 40 years and older
• Comprehensive metabolic panel

Step 3: Prescriber Evaluation and Prescription Issuance

Once a clinician confirms the diagnosis, they select the appropriate formulation. Testosterone cream or gel may suit men who want to avoid injections, prefer gradual steady-state delivery, or have specific absorption preferences. The prescriber writes an order specifying the formulation (brand or compounded), concentration, dose in milligrams, application site, and frequency.

Telehealth TRT clinics have made this process more accessible. A board-certified physician or nurse practitioner can order lab work through a national reference laboratory, review results asynchronously or via video visit, and send a prescription electronically to a compounding or retail pharmacy. The prescription requirement does not disappear in a telehealth model. Reputable telehealth programs will not prescribe testosterone without documented lab results and a clinical evaluation.

Who Should Not Use Testosterone Cream

Not every man with low energy or reduced libido is a candidate for testosterone therapy. The Endocrine Society guideline explicitly lists conditions where testosterone therapy is contraindicated or requires caution:

• Prostate cancer or elevated PSA without urologic evaluation
• Male breast cancer
• Hematocrit above 54% (polycythemia)
• Severe lower urinary tract symptoms (IPSS score above 19)
• Untreated obstructive sleep apnea
• Uncontrolled heart failure
• Active desire for fertility in the near term (testosterone suppresses sperm production)

Men who want children should be counseled about alternatives such as clomiphene citrate (an off-label use) or human chorionic gonadotropin (hCG), both of which stimulate endogenous testosterone production without suppressing the hypothalamic-pituitary axis.

Monitoring After Starting Testosterone Cream

Starting treatment is not the end of clinical involvement. It is the beginning of an ongoing monitoring relationship.

Labs at 3 to 6 Months

Most guidelines recommend checking total testosterone 3 to 6 months after starting therapy to confirm the target range has been reached. The Endocrine Society targets 400 to 700 ng/dL for most men, though optimal levels vary by individual symptom response. Hematocrit should be checked at the same visit. A hematocrit above 54% requires dose reduction or treatment pause.

PSA should be rechecked in men 40 and older at 3 to 6 months. A rise of more than 1.4 ng/mL above baseline within any 12-month period warrants urology referral.

Application Site Rotation and Transfer Prevention

Topical testosterone requires daily attention to application technique. Patients applying cream or gel to the upper arms, shoulders, or abdomen should:

• Wash hands immediately after applying
• Allow the site to dry fully before dressing
• Cover the application site with clothing when in contact with women or children
• Wash the site before skin-to-skin contact

The FDA's 2009 black-box warning for all topical testosterone products specifies these precautions in the prescribing information. Secondary exposure cases have involved children developing early pubic hair, clitoral or penile enlargement, and advanced bone age. These effects reversed after exposure stopped, but the cases underscore that topical testosterone is a real pharmaceutical with real physiologic activity.

Annual Monitoring

After the first year, stable patients typically need labs every 6 to 12 months. The monitoring panel at annual visits generally includes total testosterone, hematocrit, PSA, and a basic metabolic panel. Bone density measurement (DEXA scan) is recommended at baseline in men with osteoporosis risk and repeated every 1 to 2 years during therapy per the Endocrine Society guideline.

The Legal Risk of Obtaining Testosterone Without a Prescription

Purchasing testosterone from unregulated online sources, foreign pharmacies, or research chemical suppliers is a federal crime. Because testosterone is Schedule III, possession without a valid prescription carries penalties under 21 U.S.C. § 844. Distribution carries felony-level penalties.

Beyond the legal risk, products from unregulated sources have unknown purity. Testing by independent laboratories has identified vials and creams labeled as testosterone that contained heavy metals, bacterial contamination, incorrect concentrations, or entirely different compounds. There is no quality control, no pharmacist review, and no prescriber accountability. A 2021 review in Andrology noted that illicitly obtained testosterone products carry microbiological contamination risks absent in pharmacy-dispensed formulations.

Cost and Insurance Considerations

Branded testosterone gels and creams can cost $300 to $600 per month without insurance. Generic versions of AndroGel 1% and authorized generics have reduced that cost significantly. Compounded testosterone cream from a 503A pharmacy may run $40 to $120 per month depending on concentration and quantity, making it the most affordable route for many patients.

Medicare covers FDA-approved testosterone products when the diagnosis of hypogonadism is properly documented with ICD-10 code E29.1 (primary hypogonadism) or E23.0 (hypofunction of the pituitary gland, for secondary hypogonadism). Many commercial insurers follow similar criteria, requiring prior authorization with lab documentation.

GoodRx and similar discount programs can reduce the out-of-pocket cost of branded topicals substantially at participating pharmacies. Generic testosterone gel (1%) is available at some chains for under $60 per month with discount cards as of early 2025.